L
Lexicon Pharmaceuticals, Inc. (LXRX)
NCM – Real Time Price. Currency in USD
2.39
-0.04 (-1.44%)
Market open: Aug 12, 2026, 12:39 PM EDT
2.41
-0.02 (-0.82%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
2.39
-0.04 (-1.44%)
Market open: Aug 12, 2026, 12:39 PM EDT
2.41
-0.02 (-0.82%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Cash reserves $0.0 barely cover the upcoming debt maturities $51.4M
Total current assets $190.6M are just enough to cover Total current liabilities $0.0, indicating tight liquidity
Debt-to-equity ratio (0.3) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-10.2x) is dangerously low, suggesting debt repayment risks
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | N/A | 6.05 | 1.0 | |
| Quick ratio | N/A | 5.63 | 1.0 | |
| Debt to Equity | 0.29 | 0.30 | 8.0 | |
| Debt to Assets | 0.21 | 1.04 | 8.0 | |
| Interest coverage | -10.17 | -16.91 | 1.0 | |
| Weighted average score | 3.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 139K | 1M | 31M | 50M | 41M |
| Gross Profit | -288K | 565K | 30M | 49M | 41M |
| Operating Income | -101M | -172M | -185M | -49M | -55M |
| Net Income | -102M | -177M | -200M | -50M | -61M |
| EBITDA | -100M | -171M | -184M | -48M | -28M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -80.04 | -48.88 | 1.0 |
| Next quarter | 139.89 | 22.75 | 10 |
| Current year | -23.81 | -17.62 | 1.0 |
| Next year | -47.52 | -24.06 | 1.0 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -96.71 | -2946.49 | 999 | 14.52 | 5.0 |
| Y/Y | -97.59 | -1077.08 | -799.99 | 66.35 | 3.3 |
| 3y average | 1102.64 | -3.99 | 23.54 | -9.67 | 5.5 |
| 5y average | 631.16 | -15.58 | 10.82 | 1.42 | 5.3 |
| Weighted average score | 4.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |